Bio-Techne
TECH
#1480
Rank
A$18.11 B
Marketcap
$113.99
Share price
-0.37%
Change (1 day)
27.05%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) - Total assets

Total assets on the balance sheet as of September 2024 : A$4.19 Billion

According to Bio-Techne's latest financial reports the company's total assets are A$4.19 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Bio-Techne - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-06-30A$3.98 B19.51%
2022-06-30A$3.33 B10.74%
2021-06-30A$3.01 B2.08%
2020-06-30A$2.95 B9.95%
2019-06-30A$2.68 B24.7%
2018-06-30A$2.15 B6.14%
2017-06-30A$2.02 B34.08%
2016-06-30A$1.51 B9.11%
2015-06-30A$1.38 B51.32%
2014-06-30A$0.91 B7.58%
2013-06-30A$0.85 B21.22%
2012-06-30A$0.70 B21.58%
2011-06-30A$0.57 B-6.33%
2010-06-30A$0.61 B5.33%
2009-06-30A$0.58 B10.55%
2008-06-30A$0.52 B-1.41%
2007-06-30A$0.53 B7.69%
2006-06-30A$0.49 B28.91%
2005-06-30A$0.38 B-17.89%
2004-06-30A$0.47 B19.54%
2003-06-30A$0.39 B-7.12%
2002-06-30A$0.42 B0.78%
2001-06-30A$0.42 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
A$153.74 B 3,568.25%๐Ÿ‡บ๐Ÿ‡ธ USA
A$16.24 B 287.55%๐Ÿ‡บ๐Ÿ‡ธ USA
A$85.14 B 1,931.49%๐Ÿ‡บ๐Ÿ‡ธ USA
A$123.49 B 2,846.43%๐Ÿ‡บ๐Ÿ‡ธ USA
A$8.55 B 104.12%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
A$194.08 B 4,530.74%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.13 B-96.87%๐Ÿ‡บ๐Ÿ‡ธ USA